Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Weighted Average and Diluted) (2020 - 2025)

iSpecimen has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.74 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.74 for Q4 2025, up 88.22% from a year ago — trailing twelve months through Dec 2025 was -$2.35 (up 87.27% YoY), and the annual figure for FY2025 was -$2.28, up 87.03%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.74 at iSpecimen, down from -$0.48 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for ISPC hit a ceiling of $0.08 in Q4 2021 and a floor of -$6.77 in Q4 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.6 (2025), compared with a mean of -$1.96.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 104.95% in 2021 and later tumbled 2720.83% in 2023.
  • iSpecimen's EPS (Weighted Average and Diluted) stood at $0.08 in 2021, then plummeted by 400.0% to -$0.24 in 2022, then plummeted by 2720.83% to -$6.77 in 2023, then rose by 7.24% to -$6.28 in 2024, then surged by 88.22% to -$0.74 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.74 (Q4 2025), -$0.48 (Q3 2025), and -$0.42 (Q2 2025) per Business Quant data.